“We recognize that achieving clinical trials that include diverse populations presents an ongoing challenge,” the PhRMA trade association says in a recent addition to its white paper on Principles on […]
The U.S. Food and Drug Administration (FDA) drug and biological product centers intend, to the extent appropriate and permitted by law, to publicly post their reviews of the scientific data […]
Exciting news about potential COVID-19 vaccines in recent days serves as a reminder of how admirably the clinical trial industry has risen to the challenge of battling a worldwide health […]
“Clinical trials are critical” in the battle against the global COVID-19 pandemic, Amy Abernethy, principal deputy commissioner and acting CIO of the U.S. Food and Drug Administration (FDA), told attendees […]
Competency-based and other creative approaches are needed to address the battle for talent in the clinical research workforce.